Market Research Logo

Bronchitis Treatment - Global Market Outlook (2015-2022)

Bronchitis Treatment - Global Market Outlook (2015-2022)

According to Stratistics MRC, the Global Bronchitis Treatment Market accounted for $XX million in 2015 and is expected to grow at a CAGR of XX% to reach $XX million by 2022. Sedentary lifestyle, chemical pollutants, strict regulations to pollutant emission control, habit to cigarette smoke and adherence to a variety of international protocol are the major factors driving the market growth. Chemicals, smoke, air pollution and irritants are the risk factors for bronchitis. The most important indication of bronchitis is headache, continuous cough, nasal congestion, sore throat and fatigue.

Some of the key players in the market include GlaxoSmithKline Pharmaceuticals Limited, Boehringer Ingelheim, Osiris Therapeutics, Inc., Pfizer Inc., Reddy’s Laboratories Ltd, Sanofi Aventis, Hyundai Pharmaceutical Co., Ltd., Mucosis B.V. , Myelo Therapeutics GmbH, DBV Technologies S.A., Recipharm and Dr. Reddy’s Laboratories Ltd.

Class of Drugs Covered:
Bronchodilators
Mucolytics
Antibiotics
Anti-inflammatory Drugs

Treatments Covered:
Oxygen therapy
Drugs

End Users Covered:
Drug stores
Hospitals
Clinics

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:

Market share assessments for the regional and country level segments
Market share analysis of the top industry players
Strategic recommendations for the new entrants
Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Bronchitis Treatment Market, By Class of Drugs
5.1 Introduction
5.2 Bronchodilators
5.3 Mucolytics
5.4 Antibiotics
5.5 Anti-inflammatory Drugs
6 Global Bronchitis Treatment Market, By Treatment
6.1 Introduction
6.2 Oxygen therapy
6.3 Drugs
7 Global Bronchitis Treatment Market, By End User
7.1 Introduction
7.2 Drug stores
7.3 Hospitals
7.4 Clinics
8 Global Bronchitis Treatment Market, By Geography
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 GlaxoSmithKline Pharmaceuticals Limited
10.2 Boehringer Ingelheim
10.3 Osiris Therapeutics, Inc.
10.4 Pfizer Inc.
10.5 Reddy’s Laboratories Ltd
10.6 Sanofi Aventis
10.7 Hyundai Pharmaceutical Co., Ltd.
10.8 Mucosis B.V.
10.9 Myelo Therapeutics GmbH
10.10 DBV Technologies S.A.
10.11 Recipharm
10.12 Dr. Reddy’s Laboratories Ltd
List of Tables
Table 1 Global Bronchitis Treatment Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global Bronchitis Treatment Market Outlook, By Class of Drugs (2013-2022) ($MN)
Table 3 Global Bronchitis Treatment Market Outlook, By Bronchodilators (2013-2022) ($MN)
Table 4 Global Bronchitis Treatment Market Outlook, By Mucolytics (2013-2022) ($MN)
Table 5 Global Bronchitis Treatment Market Outlook, By Antibiotics (2013-2022) ($MN)
Table 6 Global Bronchitis Treatment Market Outlook, By Anti-inflammatory Drugs (2013-2022) ($MN)
Table 7 Global Bronchitis Treatment Market Outlook, By Treatment (2013-2022) ($MN)
Table 8 Global Bronchitis Treatment Market Outlook, By Oxygen therapy (2013-2022) ($MN)
Table 9 Global Bronchitis Treatment Market Outlook, By Drugs (2013-2022) ($MN)
Table 10 Global Bronchitis Treatment Market Outlook, By End User (2013-2022) ($MN)
Table 11 Global Bronchitis Treatment Market Outlook, By Drug stores (2013-2022) ($MN)
Table 12 Global Bronchitis Treatment Market Outlook, By Hospitals (2013-2022) ($MN)
Table 13 Global Bronchitis Treatment Market Outlook, By Clinics (2013-2022) ($MN)
Table 14 North America Bronchitis Treatment Market Outlook, By Class of Drugs (2013-2022) ($MN)
Table 15 North America Bronchitis Treatment Market Outlook, By Bronchodilators (2013-2022) ($MN)
Table 16 North America Bronchitis Treatment Market Outlook, By Mucolytics (2013-2022) ($MN)
Table 17 North America Bronchitis Treatment Market Outlook, By Antibiotics (2013-2022) ($MN)
Table 18 North America Bronchitis Treatment Market Outlook, By Anti-inflammatory Drugs (2013-2022) ($MN)
Table 19 North America Bronchitis Treatment Market Outlook, By Treatment (2013-2022) ($MN)
Table 20 North America Bronchitis Treatment Market Outlook, By Oxygen therapy (2013-2022) ($MN)
Table 21 North America Bronchitis Treatment Market Outlook, By Drugs (2013-2022) ($MN)
Table 22 North America Bronchitis Treatment Market Outlook, By End User (2013-2022) ($MN)
Table 23 North America Bronchitis Treatment Market Outlook, By Drug stores (2013-2022) ($MN)
Table 24 North America Bronchitis Treatment Market Outlook, By Hospitals (2013-2022) ($MN)
Table 25 North America Bronchitis Treatment Market Outlook, By Clinics (2013-2022) ($MN)
Table 26 Europe Bronchitis Treatment Market Outlook, By Class of Drugs (2013-2022) ($MN)
Table 27 Europe Bronchitis Treatment Market Outlook, By Bronchodilators (2013-2022) ($MN)
Table 28 Europe Bronchitis Treatment Market Outlook, By Mucolytics (2013-2022) ($MN)
Table 29 Europe Bronchitis Treatment Market Outlook, By Antibiotics (2013-2022) ($MN)
Table 30 Europe Bronchitis Treatment Market Outlook, By Anti-inflammatory Drugs (2013-2022) ($MN)
Table 31 Europe Bronchitis Treatment Market Outlook, By Treatment (2013-2022) ($MN)
Table 32 Europe Bronchitis Treatment Market Outlook, By Oxygen therapy (2013-2022) ($MN)
Table 33 Europe Bronchitis Treatment Market Outlook, By Drugs (2013-2022) ($MN)
Table 34 Europe Bronchitis Treatment Market Outlook, By End User (2013-2022) ($MN)
Table 35 Europe Bronchitis Treatment Market Outlook, By Drug stores (2013-2022) ($MN)
Table 36 Europe Bronchitis Treatment Market Outlook, By Hospitals (2013-2022) ($MN)
Table 37 Europe Bronchitis Treatment Market Outlook, By Clinics (2013-2022) ($MN)
Table 38 Asia Pacific Bronchitis Treatment Market Outlook, By Class of Drugs (2013-2022) ($MN)
Table 39 Asia Pacific Bronchitis Treatment Market Outlook, By Bronchodilators (2013-2022) ($MN)
Table 40 Asia Pacific Bronchitis Treatment Market Outlook, By Mucolytics (2013-2022) ($MN)
Table 41 Asia Pacific Bronchitis Treatment Market Outlook, By Antibiotics (2013-2022) ($MN)
Table 42 Asia Pacific Bronchitis Treatment Market Outlook, By Anti-inflammatory Drugs (2013-2022) ($MN)
Table 43 Asia Pacific Bronchitis Treatment Market Outlook, By Treatment (2013-2022) ($MN)
Table 44 Asia Pacific Bronchitis Treatment Market Outlook, By Oxygen therapy (2013-2022) ($MN)
Table 45 Asia Pacific Bronchitis Treatment Market Outlook, By Drugs (2013-2022) ($MN)
Table 46 Asia Pacific Bronchitis Treatment Market Outlook, By End User (2013-2022) ($MN)
Table 47 Asia Pacific Bronchitis Treatment Market Outlook, By Drug stores (2013-2022) ($MN)
Table 48 Asia Pacific Bronchitis Treatment Market Outlook, By Hospitals (2013-2022) ($MN)
Table 49 Asia Pacific Bronchitis Treatment Market Outlook, By Clinics (2013-2022) ($MN)
Table 50 Rest of the World Bronchitis Treatment Market Outlook, By Class of Drugs (2013-2022) ($MN)
Table 51 Rest of the World Bronchitis Treatment Market Outlook, By Bronchodilators (2013-2022) ($MN)
Table 52 Rest of the World Bronchitis Treatment Market Outlook, By Mucolytics (2013-2022) ($MN)
Table 53 Rest of the World Bronchitis Treatment Market Outlook, By Antibiotics (2013-2022) ($MN)
Table 54 Rest of the World Bronchitis Treatment Market Outlook, By Anti-inflammatory Drugs (2013-2022) ($MN)
Table 55 Rest of the World Bronchitis Treatment Market Outlook, By Treatment (2013-2022) ($MN)
Table 56 Rest of the World Bronchitis Treatment Market Outlook, By Oxygen therapy (2013-2022) ($MN)
Table 57 Rest of the World Bronchitis Treatment Market Outlook, By Drugs (2013-2022) ($MN)
Table 58 Rest of the World Bronchitis Treatment Market Outlook, By End User (2013-2022) ($MN)
Table 59 Rest of the World Bronchitis Treatment Market Outlook, By Drug stores (2013-2022) ($MN)
Table 60 Rest of the World Bronchitis Treatment Market Outlook, By Hospitals (2013-2022) ($MN)
Table 61 Rest of the World Bronchitis Treatment Market Outlook, By Clinics (2013-2022) ($MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report